/

Empresas

De

No verificado

Deciphera Pharmaceuticals, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosMultimedia

2 Comunicados de prensa

Ver todos los comunicados de prensa

15/08/2024

Multimedia

Oncología

Salud

Higiene alimentaria

Medicina - Varios

Farmacéutica

Biotecnología

Industria

U.S. Food and Drug Administration Accepts for Priority Review Deciphera’s New Drug Application for Vimseltinib for the Treatment of Patients with Tenosynovial Giant Cell Tumor (TGCT)

Fuente

Deciphera Pharmaceuticals, Inc.

Editor

1.00

0

19/07/2024

Multimedia

Biotecnología

Sanidad

Salud

Farmacéutica

Oncología

Industria

European Medicines Agency Accepts Deciphera’s Marketing Authorization Application for Vimseltinib for Treatment of Patients with Tenosynovial Giant Cell Tumor (TGCT)

Fuente

Deciphera Pharmaceuticals, Inc.

Editor

1.00

0

Seguidores

0

Compatibilidad

0